CMS should use its Innovation Center to pilot a proposal from the Medicare Payment Advisory Commission (MedPAC) to reform the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA), according to a senior fellow at Project HOPE. Gail Wilensky, PhD, writing in The New England Journal of Medicine, said a pilot based on the proposal that MedPAC submitted to Congress would provide “real-world evidence” as to whether or not its idea to eliminate the Merit-Based Incentive Payment System (MIPS) is an improvement.
CMS should use its Center for Medicare & Mediciad Innovation (CMMI) to pilot a proposal from the Medicare Payment Advisory Commission (MedPAC) to reform the Medicare Access and CHIP Reauthorization Act of 2015, or MACRA, according to a senior fellow at Project HOPE.
Gail Wilensky, PhD, writing in The New England Journal of Medicine, said a pilot based on the proposal that MedPAC submitted to Congress would provide “real-world evidence” as to whether or not its idea to eliminate the Merit-Based Incentive Payment System (MIPS) is an improvement.
In January, MedPAC recommended repealing and replacing MIPS, 1 of 2 reimbursement tracks that physicians can enroll in under MACRA. The committee called for MIPS to be replaced with a Voluntary Value Program (VVP), where 2% of clinicians' payment would be withheld if they were not enrolled in an advanced alternative payment model or chose to be evaluated on certain population-based measures.
Wilensky said a pilot would test whether the VVP is better than MIPS in terms of helping clinicians with improving their practice and identifying healthcare organizations that provide good outcomes for beneficiaries.
A pilot could also:
Wilensky wrote that while she agrees with the concerns raised by MedPAC, she likewise has concerns with their proposal to jettison MIPS altogether, citing a lack of support from medical associations, the political realities of a divided Senate and upcoming midterm elections that will make the passage of any legislation difficult, and the fact that no one knows whether the proposal will work as planned or what the unintended consequences might be.
MACRA was passed with bipartisan support.
CMS could work with different stakeholders to “develop a small set of metrics that better reflect outcomes that matter to patients. All payers could then be encouraged to use this reduced set of metrics,” Wilensky wrote.
Reference
Wilensky, GR. Will MACRA improve physician reimbursement? [published online February 28, 2017] N Engl J Med. doi: 10.1056/NEJMp1801673.
New Insights on Breast Cancer Outcomes Among Sexual, Gender Minorities
December 7th 2023Despite there being a great demand for data collection on sexual orientation and gender identity in the cancer space, individuals who identify as a sexual and gender minority remain poorly represented.
Read More
Gestational Diabetes Is a Key Population Health Opportunity
December 7th 2023Diagnosing and treating gestational diabetes can have long-term positive effects on the health of the mother and the baby, warranting a distinct focus on the condition, according to an Institute for Value-Based Medicine® event held in Cleveland, Ohio.
Read More
Refining Precision Prevention for Benign Breast Disease
December 7th 2023Many questions remain surrounding accurately classifying the risk of developing invasive breast cancer associated with the benign breast disease diagnoses of nonproliferative lesions and proliferative changes without atypia.
Read More
Exagamglogene Autotemcel Meets End Points in Severe Sickle Cell Disease, β-Thalassemia
December 7th 2023Two posters set to be presented at the 65th American Society of Hematology Annual Meeting & Exposition met their primary and secondary end points regarding exagamglogene autotemcel therapy for sickle cell disease and β-thalassemia.
Read More